As of 2026-06-16, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 1,056.52 USD. This relative valuation is based on P/E multiples. With the latest stock price at 614.73 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is 71.9%.
The range of the Relative Valuation is 740.05 - 1,296.43 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 24.2x | 20.9x |
| Forward P/E multiples | 22.1x - 26.6x | 25.3x |
| Fair Price | 740.05 - 1,296.43 | 1,056.52 |
| Upside | 20.4% - 110.9% | 71.9% |
| Date | P/E |
| 2026-06-16 | 14.57 |
| 2026-06-15 | 14.58 |
| 2026-06-12 | 14.51 |
| 2026-06-11 | 14.49 |
| 2026-06-10 | 14.26 |
| 2026-06-09 | 14.60 |
| 2026-06-08 | 14.49 |
| 2026-06-05 | 15.06 |
| 2026-06-04 | 14.90 |
| 2026-06-03 | 14.67 |
| 2026-06-02 | 14.29 |
| 2026-06-01 | 14.24 |
| 2026-05-29 | 14.57 |
| 2026-05-28 | 14.73 |
| 2026-05-27 | 14.88 |
| 2026-05-26 | 15.04 |
| 2026-05-22 | 15.14 |
| 2026-05-21 | 15.23 |
| 2026-05-20 | 15.40 |
| 2026-05-19 | 14.94 |
| 2026-05-18 | 14.92 |
| 2026-05-15 | 16.55 |
| 2026-05-14 | 16.90 |
| 2026-05-13 | 17.06 |
| 2026-05-12 | 17.15 |
| 2026-05-11 | 16.89 |
| 2026-05-08 | 16.94 |
| 2026-05-07 | 16.81 |
| 2026-05-06 | 17.09 |
| 2026-05-05 | 16.64 |
| 2026-05-04 | 16.81 |
| 2026-05-01 | 16.62 |
| 2026-04-30 | 16.76 |
| 2026-04-29 | 16.27 |
| 2026-04-28 | 17.34 |
| 2026-04-27 | 17.64 |
| 2026-04-24 | 17.81 |
| 2026-04-23 | 18.16 |
| 2026-04-22 | 17.69 |
| 2026-04-21 | 17.71 |
| 2026-04-20 | 17.76 |
| 2026-04-17 | 17.79 |
| 2026-04-16 | 17.68 |
| 2026-04-15 | 17.87 |
| 2026-04-14 | 17.91 |
| 2026-04-13 | 17.69 |
| 2026-04-10 | 17.75 |
| 2026-04-09 | 18.20 |
| 2026-04-08 | 18.38 |
| 2026-04-07 | 18.02 |